UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052353
Receipt number R000059770
Scientific Title Elucidation of pharmacokinetics of carvedilol and flecainide
Date of disclosure of the study information 2024/01/01
Last modified on 2023/09/29 17:29:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of pharmacokinetics of anti arrhythmic drugs

Acronym

Elucidation of pharmacokinetics of anti arrhythmic drugs

Scientific Title

Elucidation of pharmacokinetics of carvedilol and flecainide

Scientific Title:Acronym

Elucidation of pharmacokinetics of carvedilol and flecainide

Region

Japan


Condition

Condition

hypertension,heart disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The concentrations of carvedilol and flecainide in the cerebrospinal fluid are unknown and will be investigated.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlate the blood concentration of carvedilol and flecainide in the cerebrospinal fluid concentration

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients taking carvedilol and flecainide and for whom lumbar anesthesia is not contraindicated

Key exclusion criteria

Patients who cannot consent

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tomohiko
Middle name
Last name Ai

Organization

Juntendo University Urayasu Hospital

Division name

Clinical Laboratory Medicine

Zip code

270-0021

Address

2-1-1 Tomioka,Urayasu,Chiba

TEL

047-353-3111

Email

t-ai@juntendo.ac.jp


Public contact

Name of contact person

1st name Mirei
Middle name
Last name Kamimura

Organization

Juntendo University Urayasu Hospital

Division name

Clinical Laboratory Medicine

Zip code

270-0021

Address

2-1-1 Tomioka,Urayasu,Chiba

TEL

047-353-3111

Homepage URL


Email

m.kamimura.vo@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

internal

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University Urayasu Hospital

Address

2-1-1 Tomioka,Urayasu,Chiba

Tel

047-353-3111

Email

m.kamimura.vo@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 10 Month 06 Day

Date of IRB


Anticipated trial start date

2024 Year 01 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No special notes


Management information

Registered date

2023 Year 09 Month 29 Day

Last modified on

2023 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059770


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name